A Win For Burning Rock Biotech Limited
Wed, Aug 31, 2022 at 07:19 PM
Burning Rock Biotech Limited (BNR:NASDAQ) soared at $3.92, representing a gain of 20.6%. On Wed, Aug 31, 2022, BNR:NASDAQ touched a New 2-Week High of $3.92. The stock appeared on our News Catalysts scanner on Wed, Aug 31, 2022 at 06:05 PM in the 'BIOTECH' category. From Wed, Aug 17, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About Burning Rock Biotech Limited (BNR:NASDAQ)
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore.
Top 10 Gainers:
- Nuwellis Inc. (NUWE:NASDAQ), 121.25%
- Yiren Digital Ltd. (YRD:NYSE), 54.59%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 43.39%
- Guardforce AI Co. Limited (GFAI:NASDAQ), 34.58%
- Magic Empire Global Limited (MEGL:NASDAQ), 33.28%
- Bright Green Corporation (BGXX:NASDAQ), 32.69%
- Akerna Corp. (KERN:NASDAQ), 28.98%
- Mobilicom Limited (MOB:NASDAQ), 27.87%
- Burning Rock Biotech Limited (BNR:NASDAQ), 20.62%